tirzepatide elevated heart rate Benefits in Obesity-Related HFpEF Are Consistent Across BMI and Enhanced by Weight Loss. - Content increased heart rate on tirzepatide

, Yoshino, J

Healthcare providers may avoid prescribing Saxenda for people with: A history of pancreatitis Gallbladder problems Heart problems Kidney or liver disease Thyroid disorders (like medullary thyroid carcinomaor MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Diabetic ketoacidosis Digestion problems High cholesterol or triglyceride levels Saxenda may not be prescribed to pregnant women, women who are trying to conceive, or women who are breastfeeding

Oral chemotherapy food and drug interactions: a comprehensive review of the literature

24 (5): 4758 (4) Eun Jee Kim et al

These were most frequent during dose escalation, peaked around weeks 8-20, and were usually mild-to-moderate and transient